Kai-Jen Chuang Selected Research

Particulate Matter

12/2023	Short-term mediating effects of PM2.5 on climate-associated COPD severity.
10/2023	Associations of particulate matter, gaseous pollutants, and road traffic noise with the prevalence of asthma in children.
1/2022	Air pollution-regulated E-cadherin mediates contact inhibition of proliferation via the hippo signaling pathways in emphysema.
1/2022	Particulate matter in a motorcycle-dominated urban area: Source apportionment and cancer risk of lung deposited surface area (LDSA) concentrations.
10/2020	Alteration in angiotensin-converting enzyme 2 by PM1 during the development of emphysema in rats.
11/2019	Effects of Personal Exposures to Micro- and Nano-Particulate Matter, Black Carbon, Particle-Bound Polycyclic Aromatic Hydrocarbons, and Carbon Monoxide on Heart Rate Variability in a Panel of Healthy Older Subjects.
9/2019	Microglial activation and inflammation caused by traffic-related particulate matter.
8/2019	Chronic obstructive pulmonary disease patients have a higher risk of occurrence of pneumonia by air pollution.
2/2018	Association of PM2.5 with sleep-disordered breathing from a population-based study in Northern Taiwan urban areas.
1/2016	Particulate matter is associated with sputum culture conversion in patients with culture-positive tuberculosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kai-Jen Chuang Research Topics

Disease

11	Inflammation (Inflammations) 06/2021 - 08/2007
7	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 01/2015
4	Asthma (Bronchial Asthma) 10/2023 - 01/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 06/2007
3	Pneumonia (Pneumonitis) 11/2021 - 01/2019
2	Neoplasms (Cancer) 02/2023 - 01/2022
2	Emphysema 01/2022 - 10/2020
2	Infections 10/2020 - 01/2015
2	Tuberculosis (Tuberculoses) 01/2016 - 01/2015
1	COVID-19 01/2023
1	Dysbiosis 11/2022
1	Heart Failure 08/2021
1	Lung Injury 10/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 08/2020
1	Fatigue 06/2020
1	Lethargy 06/2020
1	Myocardial Infarction 11/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2019
1	Pleural Effusion (Pleural Effusions) 01/2019
1	Neuroblastoma 09/2018
1	Apnea 02/2018
1	Body Weight (Weight, Body) 01/2018
1	Adenocarcinoma of Lung 01/2017
1	Lung Neoplasms (Lung Cancer) 11/2016
1	Fever (Fevers) 07/2016
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 07/2016
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2016
1	Periodontal Diseases (Periodontal Disease) 01/2015
1	Periodontitis 01/2015
1	Chronic Periodontitis 01/2015
1	Acute-Phase Reaction 01/2014
1	Hypersensitivity (Allergy) 01/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2013
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2006

Drug/Important Bio-Agent (IBA)

13	Particulate MatterIBA 12/2023 - 01/2015
6	Air Pollutants (Pollutants, Air)IBA 10/2023 - 05/2006
4	Proteins (Proteins, Gene)FDA Link 09/2018 - 01/2013
3	Environmental Pollutants (Pollutants, Environmental)IBA 10/2023 - 05/2006
3	OzoneIBA 11/2021 - 05/2006
3	MetalsIBA 06/2021 - 07/2016
3	Vehicle Emissions (Emissions, Vehicle)IBA 09/2019 - 08/2007
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2015
2	CarbonIBA 08/2021 - 06/2007
2	SootIBA 09/2019 - 09/2018
2	Nitrogen DioxideIBA 02/2018 - 05/2006
2	Zinc Oxide FDA Link 01/2017 - 07/2016
2	C-Reactive ProteinIBA 11/2016 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 07/2016 - 01/2016
2	Carbon MonoxideIBA 01/2016 - 05/2006
2	Sulfates (Sulfates, Inorganic)IBA 08/2007 - 06/2007
1	CarcinogensIBA 02/2023
1	Formaldehyde (Formol)FDA Link 02/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	TolueneIBA 08/2021
1	Aromatic HydrocarbonsIBA 08/2021
1	Alkenes (Olefins)IBA 08/2021
1	AlkanesIBA 08/2021
1	Xylenes (Xylene)IBA 08/2021
1	Hormones (Hormone)IBA 06/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2021
1	Angiotensin-Converting Enzyme 2IBA 10/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2020
1	Leukocyte Elastase (Neutrophil Elastase)IBA 10/2020
1	HydrocarbonsIBA 08/2020
1	Carbon DioxideIBA 06/2020
1	Caspase 3 (Caspase-3)IBA 09/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2019
1	Oxygen (Dioxygen)IBA 02/2018
1	Sulfur DioxideIBA 02/2018
1	Pyruvic Acid (Pyruvate)IBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	AluminumIBA 01/2017
1	1,12-benzoperyleneIBA 11/2016
1	Indicators and Reagents (Reagents)IBA 11/2016
1	triphenyleneIBA 11/2016
1	1,2,5,6-dibenzanthracene (dibenz(a,h)anthracene)IBA 11/2016
1	chryseneIBA 11/2016
1	Tyrosine Kinase InhibitorsIBA 11/2016
1	Coal (Coals)IBA 11/2016
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 11/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2016
1	LigandsIBA 07/2016
1	InterleukinsIBA 07/2016
1	8-Hydroxy-2'-DeoxyguanosineIBA 07/2016
1	Receptor for Advanced Glycation End ProductsIBA 01/2016
1	Beclin-1IBA 01/2016
1	UbiquitinIBA 01/2016
1	SmokeIBA 01/2015
1	apolipoprotein FIBA 01/2015
1	Proteoglycans (Proteoglycan)IBA 01/2015
1	inter-alpha-inhibitorIBA 01/2015
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 11/2013
1	NickelIBA 01/2013
1	OvalbuminIBA 01/2013
1	SilverIBA 01/2013
1	Immunoglobulin E (IgE)IBA 01/2013
1	LipidsIBA 01/2011
1	Blood Glucose (Blood Sugar)IBA 01/2011